Il Quality Risk Management secondo ICH Q9
Il 26 febbraio 2021 alle ore 9:00 nell’ambito del progetto [...]
Diatheva for WORLD ANTIMICROBIAL AWARENESS WEEK
This week (18-24 November) is the World Antimicrobial Awareness Week [...]
Diatheva is excited to announce the launch of our new website
Diatheva is excited to announce the launch of our new [...]
Diatheva announces participation at BIO-Europe® digital 26th Annual International Partnering Conference
Diatheva announces participation at BIO-Europe® digital 26th Annual International Partnering [...]
The importance of detecting Listeria Monocytogenes
In 16.6% of spontaneous abortion cases L. monocytogenes is the [...]
DIATHEVA launches for the first time PBRT 2.0
The PBRT (PCR Based Replicon Typing) is an essential [...]
Diatheva coordinates: PrInT-Age “Un approccio integrato per la promozione della salute degli anziani e delle persone fragili: prevenzione delle infezioni, integrazione nutrizionale e terapie personalizzate”
Print-Age is a POR MARCHE FESR 2014-2020 funded project (Asse [...]
BIO 2016 : DIATHEVA presents “scFv 2G8” monoclonal antibody a new approach to fungal infections
DIATHEVA presented a new product in pipeline "scFv 2G8" [...]
New pubblication Diatheva’s pipeline antibody therapeutics
Diatheva’s pipeline antibody-based therapies is designated to address significant unmet [...]